These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23251221)

  • 1. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
    Cham CM; Ko K; Niewold TB
    Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factors in human lupus pathogenesis.
    Salloum R; Niewold TB
    Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
    Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
    Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IRF5 hyperactivation protects from lupus onset and severity.
    Song S; De S; Nelson V; Chopra S; LaPan M; Kampta K; Sun S; He M; Thompson CD; Li D; Shih T; Tan N; Al-Abed Y; Capitle E; Aranow C; Mackay M; Clapp WL; Barnes BJ
    J Clin Invest; 2020 Dec; 130(12):6700-6717. PubMed ID: 32897883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.
    Barnes BJ
    Curr Rheumatol Rep; 2019 Jan; 21(1):2. PubMed ID: 30645688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factors: critical mediators of human lupus.
    Jensen MA; Niewold TB
    Transl Res; 2015 Feb; 165(2):283-95. PubMed ID: 25445206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
    Brune Z; Rice MR; Barnes BJ
    Front Immunol; 2020; 11():1143. PubMed ID: 32582209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors.
    Shu J; Li L; Zhou LB; Qian J; Fan ZD; Zhuang LL; Wang LL; Jin R; Yu HG; Zhou GP
    Oncotarget; 2017 Jul; 8(29):47184-47194. PubMed ID: 28525378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
    Ban T; Sato GR; Tamura T
    Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics and biology of Irf5-mediated signaling in lupus.
    Kozyrev SV; Alarcon-Riquelme ME
    Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching.
    Feng D; Yang L; Bi X; Stone RC; Patel P; Barnes BJ
    Eur J Immunol; 2012 Jun; 42(6):1477-87. PubMed ID: 22678902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.
    Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
    Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
    Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T
    Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
    Ban T; Kikuchi M; Sato GR; Manabe A; Tagata N; Harita K; Nishiyama A; Nishimura K; Yoshimi R; Kirino Y; Yanai H; Matsumoto Y; Suzuki S; Hihara H; Ito M; Tsukahara K; Yoshimatsu K; Yamamoto T; Taniguchi T; Nakajima H; Ito S; Tamura T
    Nat Commun; 2021 Jul; 12(1):4379. PubMed ID: 34282144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.